Promise and pitfalls of quantitative imaging in oncology clinical trials-Reference-Cited by-同舟云学术

Promise and pitfalls of quantitative imaging in oncology clinical trials

Published:2012-11 Issue:9 Volume:30 Page:1301-1312
ISSN:0730-725X
Container-title:Magnetic Resonance Imaging
language:en
Short-container-title:Magnetic Resonance Imaging

Author:

Kurland Brenda F.,Gerstner Elizabeth R.,Mountz James M.,Schwartz Lawrence H.,Ryan Christopher W.,Graham Michael M.,Buatti John M.,Fennessy Fiona M.,Eikman Edward A.,Kumar Virendra,Forster Kenneth M.,Wahl Richard L.,Lieberman Frank S.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Biomedical Engineering,Biophysics

Reference102 articles.

1. Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents;Dancey;Clin Cancer Res,2010

2. Biomarkers and surrogate end points — the challenge of statistical validation;Buyse;Nat Rev Clin Oncol,2010

3. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors;Wahl;J Nucl Med,2009

4. Randomized phase III clinical trial designs for targeted agents;Hoering;Clin Cancer Res,2008

5. Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology;Simon;Per Med,2010

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microfluidic Platform for Generating and Releasing Patient‐Derived Cancer Organoids with Diverse Shapes: Insight into Shape‐Dependent Tumor Growth;Advanced Materials;2024-09-14

2. Improving performance in colorectal cancer histology decomposition using deep and ensemble machine learning;Heliyon;2024-09

3. Differentiation of granulomatous nodules with lobulation and spiculation signs from solid lung adenocarcinomas using a CT deep learning model;BMC Cancer;2024-07-22

4. Dynamic Contrast-Enhanced (DCE) MRI;Magnetic Resonance Imaging Clinics of North America;2024-02

5. Future Directions and Challenges in Overcoming Drug Resistance in Cancer;Drug Resistance in Cancer: Mechanisms and Strategies;2024